{"id":"W2947918745","doi":"10.1200/jco.2019.37.15_suppl.tps597","title":"NATALEE: Phase III study of ribociclib (RIBO) + endocrine therapy (ET) as adjuvant treatment in hormone receptor–positive (HR+), human epidermal growth factor receptor 2–negative (HER2–) early breast cancer (EBC).","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; University of Calgary","funders":"","keywords":"Medicine; Letrozole; Anastrozole; Internal medicine; Randomization; Goserelin; Breast cancer; Cancer; Oncology; Metastatic breast cancer; Adjuvant; Randomized controlled trial; Tamoxifen","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001302193,0.0005228652,0.003795918,0.0003493933,0.00006679388,0.00001301789,0.0003453752,0.0003361403,0.002019969],"category_scores_gemma":[0.0004478276,0.0003666315,0.0006557614,0.0003899572,0.0004124349,0.0005068841,0.00008896377,0.001484972,0.00003972575],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001271902,"about_ca_system_score_gemma":0.001731934,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003197316,"about_ca_topic_score_gemma":0.0004733253,"domain_scores_codex":[0.9929301,0.00143804,0.003677152,0.0005919014,0.0007768698,0.0005859871],"domain_scores_gemma":[0.992031,0.002412351,0.003524623,0.0004046923,0.001108729,0.0005185662],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1513799,0.04532681,0.2701401,0.00004089223,0.00510747,0.001007234,0.01230197,0.00003323001,0.04076853,0.0001061139,0.000287397,0.4735003],"study_design_scores_gemma":[0.1511884,0.1162395,0.7201489,0.00024039,0.0002748347,0.000323368,0.00278657,0.000006398107,0.005527506,0.0001833972,0.002746741,0.000334056],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9907476,0.001753924,0.0000163502,0.004039153,0.0009501848,0.001894419,0.0001939928,0.00002290946,0.0003815094],"genre_scores_gemma":[0.993575,0.003163166,0.0005818381,0.0009941148,0.0009964113,0.00008196153,0.00001751772,0.00007769076,0.0005122756],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4731662,"threshold_uncertainty_score":0.9998786,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07142779416144623,"score_gpt":0.473287293458567,"score_spread":0.4018594992971208,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}